aInstitute for Glycomics, Griffith University, Gold Coast, QLD, Australia
bInstitute of Technology, University of Tartu, Tartu, Estonia
cArbovirus Emerging Diseases Unit, Centre for Infectious Diseases and Microbiology Laboratory Services, Westmead Hospital, Westmead, NSW, Australia
cSchool of Medical Science and Griffith Health Institute, Griffith University, Gold Coast, QLD, Australia
eSt. Vincent's Institute of Medical Research and Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Melbourne, VIC, Australia
Citation Chen W, Foo S-S, Taylor A, Lulla A, Merits A, Hueston L, Forwood MR, Walsh NC, Sims NA, Herrero LJ, Mahalingam S. 2015. Correction for Chen et al., Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J Virol 89:12232. doi:10.1128/JVI.02114-15.